
Exact Sciences Corporation EXAS
€ 87.69
0.35%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Exact Sciences Corporation P/CF 2011-2026 | EXAS
P/CF Jährlich Exact Sciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.3 | 72.2 | -48.7 | -128 | 152 | -42.8 | -48.8 | -40.6 | -12.8 | -3.88 | -23.4 | -18.6 | -14.4 | -16 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 152 | -128 | -9.25 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 23.35 | -0.21 % | $ 251 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 23.27 | 0.78 % | $ 99.4 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-0.0515 | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
22.7 | $ 235.37 | 0.14 % | $ 172 B | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 12.04 | -6.67 % | $ 342 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 6.09 | -0.49 % | $ 179 M | ||
|
DexCom
DXCM
|
65.2 | $ 67.79 | -0.94 % | $ 26.2 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 39.08 | -2.03 % | $ 1.09 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-28.3 | $ 17.15 | -0.44 % | $ 922 M | ||
|
Celcuity
CELC
|
-4.78 | $ 105.14 | 0.45 % | $ 4.15 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-0.00965 | $ 3.42 | - | $ 109 K | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 27.97 | 0.29 % | $ 846 M | ||
|
IQVIA Holdings
IQV
|
13.1 | $ 245.35 | 0.9 % | $ 44.5 B | ||
|
RadNet
RDNT
|
15.8 | $ 78.75 | 0.47 % | $ 5.75 B | ||
|
Guardant Health
GH
|
-24.4 | $ 107.06 | -1.54 % | $ 13.1 B | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
19.6 | $ 141.04 | -3.29 % | $ 22.4 B | ||
|
Charles River Laboratories International
CRL
|
11.6 | $ 218.88 | 1.53 % | $ 11.2 B | ||
|
Natera
NTRA
|
-12.3 | $ 234.3 | -2.2 % | $ 23.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.3 | $ 175.68 | -1.19 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-1.89 | $ 5.42 | -2.96 % | $ 703 M | ||
|
Pacific Biosciences of California
PACB
|
-5.45 | $ 2.03 | -0.49 % | $ 515 M | ||
|
Laboratory Corporation of America Holdings
LH
|
13.3 | $ 253.11 | -0.61 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 183.94 | -2.27 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
40.5 | $ 712.09 | -0.04 % | $ 58.7 B | ||
|
Lantheus Holdings
LNTH
|
11.9 | $ 66.5 | -2.0 % | $ 4.6 B | ||
|
Agilent Technologies
A
|
28.3 | $ 148.13 | 1.63 % | $ 45 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.74 | -4.79 % | $ 6.29 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | $ 48.1 | -0.72 % | $ 10.7 B | ||
|
Bioventus
BVS
|
22.9 | $ 7.86 | -1.75 % | $ 492 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 29.58 | 0.51 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-2.44 | $ 25.52 | 10.53 % | $ 33.1 M |